Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81

News > All

Total search results: 9810 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 96 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Micromet, Inc.. (11/9/10). "Press Release: Micromet Reports Third Quarter 2010 Financial Results". Bethesda, MD. 2010-11-09
Micromet, Inc.. (11/9/10). "Press Release: Micromet to Provide Update on BiTE Antibody R&D Programs at 2010 American Society of Hematology Annual Meeting. Long-term Follow-Up Data from Phase 2 Blinatumomab ALL Trial Accepted for Oral Presentation". Bethe 2010-11-09
Tecan Group Ltd.. (11/9/10). "Press Release: Strengthening of the Tecan Group Executive Committee. Heads Appointed for the Two New Business Segments". Männedorf. 2010-11-09
Bruker Corporation. (11/9/10). "Press Release: The Institute for Medical Microbiology of the University Medical Center Goettingen Selects Bruker’s MALDI Biotyper for Bacterial and Fungal Identification". Bremen. 2010-11-09
Epigenomics AG. (11/9/10). "Press Release: Epigenomics AG Releases 9-Months Financial Report". Berlin. 2010-11-09
Advion BioSystems, Inc.. (11/9/10). "Press Release: Advion NanoTek Microfluidic Synthesis System Featured at Annual Meeting of European Association of Nuclear Medicine (EANM)". Ithaca, NY. 2010-11-09
mtm laboratories AG. (11/8/10). "Press Release: mtm laboratories Extends Series C Financing Round by EUR 7 Million ($9.7 Million)". Heidelberg. 2010-11-08
Micromet, Inc.. (11/8/10). "Press Release: Micromet to Advance BiTE Antibody MT112/BAY 2010112 into IND-enabling Preclinical Development Activities in Collaboration with Bayer Schering Pharma. Milestone Achievement Triggers 2.5 Million Euro Payment to Mi 2010-11-08
Probiodrug AG. (11/8/10). "Press Release: Probiodrug to Present at the Lazard Capital Markets 7th Annual Healthcare Conference in New York City". Halle (Saale). 2010-11-08
Qiagen N.V.. (11/8/10). "Press Release: Qiagen Reports Third Quarter 2010 Results". Venlo. 2010-11-08
BMBF. (11/8/10). "Pressemitteilung: Expertenjury wählt Standorte für Deutsche Zentren der Gesundheitsforschung. 27 Partnerstandorte müssen nun in der zweiten Runde des BMB-Wettbewers Gesamtkonzepte vorlegen – Schavan. »Wichtiges Etappenziel erreicht«". 2010-11-08
BMBF. (11/8/10). "Pressemitteilung: Deutsches Zentrum für Diabetesforschung eröffnet. Staatssektretär Braun »Neue Perspektiven für Prävention, Therapie und Diagnose«". 2010-11-08
Bayer AG. (11/8/10). "Press Release: Strategic Realignment of Brand Portfolio. Bayer Raises Its Brand Profile – Focus on Umbrella Brand and Product Brands to Create Value". Leverkusen. 2010-11-08
AiCuris GmbH & Co. KG. (11/5/10). "Press Release: AiCuris Presents Preclinical and Phase 1 Data of Its Anti-HSV Drug AIC316". Wuppertal. 2010-11-05
Epigenomics AG. (11/5/10). "Press Release: Epigenomics Signs Distribution Deal with DPC for Epi proColon in Middle East. Third Distribution Agreement for Epi proColon Completes the Picture for the Middle East". Berlin & Seattle, WA. 2010-11-05
Agennix AG. (11/5/10). "Press Release: Agennix Awarded Approximately $490,000 under U.S. Qualifying Therapeutic Discovery Project Grant Program". Planegg, Princeton, NJ & Houston, TX. 2010-11-05
4SC AG. (11/4/10). "Press Release: 4SC’s Vidofludimus Meets Primary Endpoint with Excellent Response Rate in IBD Trial. Vidofludimus Generates a Response Rate of 88.5% for the Treatment of Patients with Crohn’s Disease and Ulcerative Colitis". Planegg-Ma 2010-11-04
Biocrea GmbH. (11/4/10). "Press Release: Biocrea Acquires CNS Pipeline and PDE Inhibitor Platform from Biotie Therapies Corp., Announces Corporate Strategy. New Entity Will Be Based in Radebeul, Germany". Radebeul. 2010-11-04
bioMérieux, Inc.. (11/4/10). "Press Release: bioMérieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics". Marcy l’Étoile & Lausanne. 2010-11-04
bioMérieux, Inc.. (11/4/10). "Press Release: Presentation. bioMérieux and Biocartis – a Strategic Partnership in Molecular Diagnostics". 2010-11-04
Qiagen. (11/4/10). "Press Release: Qiagen Launches Standardized Solutions for Molecular Analysis of FFPE Samples". Hilden & Germantown, MD. 2010-11-04
Apeiron Biologics AG. (11/4/10). "Press Release: Apeiron Acquires Rights to New Clinical Stage Project. License for Therapeutic Enzyme for Treatment of Inflammatory Conditions Marks First Step of Project Portfolio Build-up". Vienna. 2010-11-04
Merck KGaA. (11/4/10). "Press Release: Merck KGaA. Top-line Results of Long-term Study of Safinamide as Add-on Treatment to Levodopa in Advanced Parkinson’s Disease". Darmstadt. 2010-11-04
MorphoSys AG. (11/4/10). "Press Release: AbD Serotec Secures Exclusive Worldwide License to Research Antibody from The Institute of Cancer Research. Deal Strenghtens AbD Serotec’s Position as Source of Core Reagents to Study Cell Proliferation and Cell K 2010-11-04
Roche. (11/4/10). "Press Release: Roche Reports Promising Phase II Results with New Targeted Approach in Advanced Melanoma. New Data on Inhibition of Advanced BRAF Mutated Melanoma". Basel. 2010-11-04
Roche. (11/4/10). "Press Release: Helixxa Certified to Provide NimbleGen Array Services in Brazil". Madison, WI. 2010-11-04
Sigma-Aldrich Corporation. (11/4/10). "Press Release: Sigma Life Science Collaborates with The Jackson Laboratory for Distribution of Genetically Engineered Mice". St. Louis, MO. 2010-11-04
Bayerisches Finanzministerium. (11/4/10). "Pressemitteilung: Fahrenschon – »Bio-High-Tech in Martinsried mit der IZB-GmbH als verlässlichem Partner«". 2010-11-04
Scienion AG. (11/3/10). "Press Release: Positive Feedback on Scienion’s Unique Workshop on the IVD Value Chain. »From Sample to Assay – From R&D to IVD« Was the Title of a Two-day Workshop Scienion AG Hosted in Berlin Recently". Dortmund & Berlin. 2010-11-03
Scienion AG. (11/3/10). "Press Release: Appendix. Final Program & Abstracts of Workshop »From Sample to Assay – from F&D to IVD« in Berlin, 21–22 October 2010". Dortmund & Berlin. 2010-11-03
Wilex AG. (11/3/10). "Press Release: Wilex AG Announces Acquisition of Heidelberg Pharma AG. Access to Novel Antibody Drug Conjugate Platform Technogy for Therapeutic Antibodies in Cancer Treatment". Munich. 2010-11-03
Agilent Technologies Inc.. (11/3/10). "Press Release: Agilent Technologies Appoints Beckman Coulter Genomics First Certified Service Provider for Target Enrichment and Microarrays". Santa Clara, CA & Danvers, MA. 2010-11-03
Bayer AG. (11/3/10). "Press Release: Bayer to Strenghten Animal Health Business in Asia Pacific and Latin America. Bayer Acquires Animal Health Company Bomac in New Zealand". Auckland & Leverkusen. 2010-11-03
GATC Biotech AG. (11/2/10). "Press Release: GATC Subsidiary LifeCodexx Appoints Head of Commercial Operations. Former Brahms Sales Manager Boosts LifeCodexx Team". Constance. 2010-11-02
Protagen AG. (11/2/10). "Press Release: Protagen at the European Antibody Congress 2010". Dortmund. 2010-11-02
Delenex Therapeutics AG. (11/2/10). "Press Release: Delenex Secures Series A Financing. Delenex Therapeutics AG Has Announced the Closing of Its Series A Venture Equity Investment Round Securing CHF 13.5 Million". Zürich-Schlieren. 2010-11-02
ATMI, Inc.. (11/2/10). "Press Release: ATMI Acquires European Biotech Firm to Expand Portfolio of Bioprocess Manufacturing and Single-use Technology Products for the Life Sciences Industry". Danbury, CT. 2010-11-02
Nycomed. (11/1/10). "Press Release: Nycomed to Acquire Majority Stake in Guangdong Techpool Bio-Pharma". 2010-11-01
SeSaM-Biotech GmbH. (11/1/10). "Press Release: SeSaM Running Under New Management". Bremen. 2010-11-01
Probiodrug AG. (11/1/10). "Press Release: Probiodrug to Present Novel Findings on the Pathogenesis of Alzheimer’s Disease at Neuroscience 2010". Halle (Saale). 2010-11-01
Roche. (11/1/10). "Press Release: Roche Partners with DNA Electronics to Develop Semiconductor-based Sequencing System". Branford, CT. 2010-11-01
SGS S.A.. (11/1/10). "Press Release: SGS Acquires the M-Scan Group". 2010-11-01
Analytik Jena AG. (11/1/10). "Press Release: Analytik Jena Wins Major Order in Poland. Analytik Jena AG Is Kicking Off the Financial Year with a Large-scale Follow-up Project for the Polish Inspectorate of Environmental Protection (GIOS)". 2010-11-01
Rittershaus Rechtsanwälte. (11/1/10). "Pressemitteilung: Rittershaus verstärkt die Corporate-Praxis am Standort Mannheim". 2010-11-01
MorphoSys AG. (10/29/10). "Press Release: MorphoSys AG Reports Nine Months 2010 Results". 2010-10-29
Bruker Corporation. (10/29/10). "Press Release: National High Magnetic Field Laboratory at Florida State University Selects Bruker to Build World’s First 21.0 Tesla FT-ICR Magnet". Cambridge, MA. 2010-10-29
Sygnis Pharma AG. (10/29/10). "Press Release: Sygnis Pharma AG Announces Strategic Restructuring". Heidelberg. 2010-10-29
Roche. (10/29/10). "Press Release: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer". Basel. 2010-10-29
Bruker Corporation. (10/28/10). "Press Release: Bruker Reports Financial Results for the Third Quarter of 2010". Billerica, MA. 2010-10-28
Epigenomics AG. (10/28/10). "Press Release: Epigenomics Signs Distribution Deal with DATEKS for Epi proColon in Turkey. Second Distributor to Be Signed-up for Epi proColon – More Expected to Come Shortly". Berlin & Seattle, WA. 2010-10-28
Evotec AG. (10/28/10). "Press Release: License and Collaboration Agreement with Jingxin Pharma for EVT 201". Hamburg. 2010-10-28
Merck KGaA. (10/28/10). "Press Release: Merck KGaA Sells Théramex to Teva for EUR 265 Million. Acquisition Will Provide Teva with a Strong Platform to Expand Its Global Women’s Health Business". Darmstadt. 2010-10-28
Sygnis Pharma AG. (10/28/10). "Press Release: Dr. Alfred Bach Resigns as CEO of Sygnis Pharma AG". Heidelberg. 2010-10-28
Evotec AG. (10/27/10). "Press Release: Pain Alliance with Apeiron Biologics". Hamburg. 2010-10-27
Thermo Fisher Scientific Inc.. (10/27/10). "Press Release: Thermo Fisher Scientific Reports Third Quarter 2010 Results". Waltham, MA. 2010-10-27
Epigenomics AG. (10/27/10). "Press Release: Epigenomics AG. New Clinical Data for Septin9 Colorectal Cancer Blood Test Presented at UEGW. Independent Validation of Laboratory Test Used in PRESEPT Study Shows that the Test Finds 86% of the Cancers". Berli 2010-10-27
European ScreeningPort GmbH. (10/27/10). "Press Release: European ScreeningPort and Merck KGaA Sign Research Agreement". Hamburg. 2010-10-27
Universitätsklinikum Jena. (10/27/10). "Pressemitteilung: Weitere Stärkung für die Sepsis-Forschung in Jena. Am Universitätsklinikum Jena arbeitet das Integrierte Forschungs- und Behandlungszentrum für Sepsis und Sepsisfolgen". 2010-10-27
High-Tech Gründerfonds Management GmbH. (10/27/10). "Press Release: Second Financing Round for Heppe Medical Chitosan GmbH with KI Kapital and High-Tech Gründerfonds". Bonn, Halle & Frankfurt am Main. 2010-10-27
Signature Diagnostics AG. (10/27/10). "Press Release: Signature Diagnostics to Present Company’s Blood-based Colorectal Cancer Screening Strategy at the 18th UEGW Congress in Barcelona. Advantages of Detector C and Dectector C/Plus in Early Detection of 2010-10-27
Panatecs GmbH. (10/26/10). "Press Release: Mass Spectrometric Quantification of Proteinaceous Active Substances from Plants". 2010-10-26
Merck KGaA. (10/26/10). "Press Release: Q3/2010. Merck KGaA Profit After Tax Jumps 45% to EUR 215 Million". Darmstadt. 2010-10-26
Merck KGaA. (10/26/10). "Press Release: 3rd Quarter 2010 Results. Presentation – Dr. Michael Becker and Elmar Schnee". Darmstadt. 2010-10-26
4SC AG. (10/26/10). "Press Release: 4SC Announces Initial Phase II Data from the SAPHIRE Study with Resminostat at the 8th International Symposium on Hodgkin Lymphoma". Planegg-Martinsried. 2010-10-26
MacroGenics, Inc.. (10/26/10). "Press Release: Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART-based Antibody Therapeutics". Ingelheim & Rockville, MD. 2010-10-26
Becton, Dickinson and Company. (10/25/10). "Press Release: BD Diagnostics and Lonza Collaborate to Commercialize the Lonza microCompass Molecular Assays on the BD MAX System". Baltimore, MD & Basel. 2010-10-25
Evolva Holding S.A.. (10/25/10). "Press Release: Evolva and Abunda Widen Collaboration in the Field of Human Nutrition". Reinach. 2010-10-25
Intercell AG. (10/25/10). "Press Release: Intercell Reports Positive Results from Its Phase II Pseudomonas aeruginosa Investigational Vaccine Study for Certain Hospital-acquired Infections". Vienna. 2010-10-25
Life Sciences Bremen (LSB). (10/22/10). "Pressemitteilung: 8. Bremer Life Sciences-Forum zu Gast im Max-Planck-Institut in Bremen. Brandaktuelles Thema »Technologietransfer« wird von verschiedenen Seiten beleuchtet". Bremen. 2010-10-22
Epigenomics AG. (10/22/10). "Press Release: Epigenomics AG to Update on Clinical Studies with Septin9 Blood Test for Colorectal Cancer at Two Conferences in Europe and the US". Berlin & Seattle, WA. 2010-10-22
bioMérieux, Inc.. (10/22/10). "Press Release: Business Review for the Nine Months Ended September 30, 2010". Marcy l’Étoile. 2010-10-22
Gesundheitswirtschaft Nordwest e. V.. (10/22/10). "Pressemitteilung: Geschäftsstelle des Gesundheitswirtschaft Nordwest e. V. nimmt ihre Arbeit auf". 2010-10-22
Bruker Corporation. (10/21/10). "Press Release: Bruker Announces Successful Installation of Record-setting Ultra-high Field 17 Tesla Preclinical MRI System at NeuroSpin Research Center in France". Paris. 2010-10-21
Actelion Ltd.. (10/21/10). "Press Release: Actelion Announces Third Quarter 2010 Financial Results". Allschwil. 2010-10-21
Actelion Ltd.. (10/21/10). "Press Release: Actelion Announces CHF 800 Million Share Repurchase Program". Allschwil. 2010-10-21
Bioeconomy Science Centre (BioSC). (10/21/10). "Pressemitteilung: Zentrum für Bioökonomieforschung gegründet. Aachen, Bonn, Düsseldorf und Jülich kooperieren in europaweit einmaligen integrativen Forschungsnetzwerk". 2010-10-21
Roche. (10/21/10). "Press Release: FDA Approves Herceptin for HER2-positive Metastatic Stomach Cancer. First Targeted Medicine Shown to Improve Overall Survival in HER2-positive Stomach and Gastroesophageal Junction Cancers". 2010-10-21
Intercell AG. (10/21/10). "Press Release: Intercell and Romark Join Forces in Combining Therapies against Hepatitis C". Vienna. 2010-10-21
Epigenomics AG. (10/20/10). "Press Release: Epigenomics’ Licensee ARUP Reports Excellent Validation Results for Septin9 Colorectal Cancer Blood Test. Presentation at ASCO – NCI – EORTC Molecular Markers Meeting". Berlin & Seattle, WA. 2010-10-20
Sygnis Pharma AG. (10/20/10). "Press Release: Sygnis Proposes Reduction of Share Capital to Improve Flexibility on Capital Markets". Heidelberg. 2010-10-20
High-Tech Gründerfonds Management GmbH. (10/20/10). "Press Release: High-Tech Gründerfonds and Bayern Kapital Invest in Technology for Stroke Prevention. Hight-Tech Gründerfonds and Bayern Capital Finance Curefab to Develop Innvoative Tools to Enhance Ea 2010-10-20
Bruker Corporation. (10/19/10). "Press Release: Bruker Energy & Supercon Technologies Enters Into iSFCL Collaboration Agreement with the Center for Advanced Power Systems at Florida State University". Billerica, MA. 2010-10-19
European ScreeningPort GmbH. (10/19/10). "Press Release: New Screening Strategy for Epigenetic Targets. European ScreeningPort Forms Strategic Alliance with Hypha Discovery to Access New Natural Products Screening Library". London & Hamburg. 2010-10-19
MorphoSys AG. (10/19/10). "Press Release: MorphoSys Opts for Second Pre-development Program within Strategic Antibody Alliance. Further Expansion of the Company’s Proprietary Development Activities". 2010-10-19
Roche. (10/19/10). "Press Release: Roche and Fluidigm Corporation Enter Worldwide Co-promotion Agreement for 454 Sequencing Systems and Access Array Platform". Branford, CT & South San Francisco, CA. 2010-10-19
BioRegioN. (10/18/10). "Pressemitteilung: BiomeTI an EU-Projekt zur Förderung medizinischer Bildgebung beteiligt". 2010-10-18
Epigenomics AG. (10/18/10). "Press Release: Epigenomics Licensee ARUP to Present Clinical Data on Colorectal Cancer Blood Test at US Cancer Conference". Berlin & Seattle, WA. 2010-10-18
Roche. (10/15/10). "Press Release: Phase II Study with Ocrelizumab Shows Significant Reduction in Disease Activity fo Multiple Sclerosis Patients". Basel. 2010-10-15
Paion AG. (10/15/10). "Press Release: Paion Expands Desmoteplase Agreement with Lundbeck. Paion Grants to Lundbeck Research Rights and Access to Potential Follow-up Compounds". Aachen. 2010-10-15
High-Tech Gründerfonds Management GmbH. (10/15/10). "Press Release: Capital for Laser-based Photoacoustics. High-Tech Gründerfonds and MAZ level one Investing about EUR 550k in PAS-Analytik GmbH". Bonn & Hamburg. 2010-10-15
MorphoSys AG. (10/14/10). "Press Release: AbD Serotec Selected as Preferred Supplier for Custom Monoclonal Antibody Generation by Research Councils UK for UK Research". 2010-10-14
Tecan Group Ltd.. (10/14/10). "Press Release: Automation Increases Neonatal Screening Throughput". Männedorf. 2010-10-14
Cellzome. (10/14/10). "Press Release: Cellzome Publication Demonstrates Utility of Chemical Proteomics Approach for Drug Profiling in Patient Material". Heidelberg. 2010-10-14
MicroDiscovery GmbH. (10/13/10). "Press Release: Protagen AG and MicroDiscovery GmbH Cooperate in Biomarker Development". Berlin & Dortmund. 2010-10-13
Evotec AG. (10/13/10). "Press Release: Voting Rights. Publication Pursuant to §26 Sect. 1 WpHG (the German Securitites Trading Act) with the Aim of Pan-European Distribution". Hamburg. 2010-10-13
Omnilab-Laborzentrum GmbH & Co. KG. (10/13/10). "Pressemitteilung: Veranstaltungshinweis. OMNILAB Labormesse zum Tag der Chemie am 04. November 2010 an der Universität Oldenburg". Bremen. 2010-10-13
Roche. (10/13/10). "Press Release: Roche Diagnostics and Alere Announce Collaboration on Natriuretic Peptides". Basel. 2010-10-13
Wilex AG. (10/13/10). "Press Release: Wilex Publishes 9-Month Financial Report 2010. Mandatory Offer from dievini Hopp BioTech Closed". Munich. 2010-10-13
Wilex AG. (10/13/10). "Presentation 9-Month Financial Report 2010. 13 October 2010". Munich. 2010-10-13
MorphoSys AG. (10/12/10). "Press Release: MorphoSys and Proteros Biostructures Receive Research Grant to Develop New Technology Platform for Structure-based Engineering of Antibodies". 2010-10-12
next pagenext page 1 2 3 ... 96 97 98 99  next pagenext page


Picture [iito] Männer Ballett 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top